{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994906",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994906_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"acebutolol\" outputclass=\"int-drug\">Acebutolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Acebutolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Acebutolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994907",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994907_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"amitriptyline\" outputclass=\"int-drug\">Amitriptyline</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Amitriptyline   increases   the effects of   noradrenaline/norepinephrine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amitriptyline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994908",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994908_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">Noradrenaline/norepinephrine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"apraclonidine\" outputclass=\"int-drug\">apraclonidine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Noradrenaline/norepinephrine   is predicted to   decrease   the effects of   apraclonidine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Apraclonidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994909",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994909_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"atenolol\" outputclass=\"int-drug\">Atenolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Atenolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atenolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994910",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994910_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"betaxolol\" outputclass=\"int-drug\">Betaxolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Betaxolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Betaxolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994911",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994911_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"bisoprolol\" outputclass=\"int-drug\">Bisoprolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Bisoprolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bisoprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994912",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994912_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"carvedilol\" outputclass=\"int-drug\">Carvedilol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Carvedilol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carvedilol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994913",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994913_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"celiprolol\" outputclass=\"int-drug\">Celiprolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Celiprolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Celiprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994914",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994914_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"clomipramine\" outputclass=\"int-drug\">Clomipramine</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Clomipramine   increases   the effects of   noradrenaline/norepinephrine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clomipramine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994915",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994915_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dosulepin\" outputclass=\"int-drug\">Dosulepin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dosulepin   increases   the effects of   noradrenaline/norepinephrine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dosulepin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994916",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994916_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"doxepin\" outputclass=\"int-drug\">Doxepin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Doxepin   increases   the effects of   noradrenaline/norepinephrine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Doxepin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994917",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994917_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"entacapone\" outputclass=\"int-drug\">Entacapone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of cardiovascular adverse effects when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Entacapone   is predicted to   increase   the risk of cardiovascular adverse effects when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Entacapone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994918",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994918_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ergometrine\" outputclass=\"int-drug\">Ergometrine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of peripheral vasoconstriction when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ergometrine   is predicted to   increase   the risk of peripheral vasoconstriction when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ergometrine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994919",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994919_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"esmolol\" outputclass=\"int-drug\">Esmolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Esmolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Esmolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994920",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994920_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"imipramine\" outputclass=\"int-drug\">Imipramine</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Imipramine   increases   the effects of   noradrenaline/norepinephrine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Imipramine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994921",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994921_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">Noradrenaline/norepinephrine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"isocarboxazid\" outputclass=\"int-drug\">isocarboxazid</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for 14 days after stopping the MAOI</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Noradrenaline/norepinephrine   is predicted to   increase   the risk of a hypertensive crisis when given with   isocarboxazid .  Manufacturer advises avoid and for 14 days after stopping the MAOI .    \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Isocarboxazid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994922",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994922_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"labetalol\" outputclass=\"int-drug\">Labetalol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Labetalol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Labetalol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994923",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994923_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"levobunolol\" outputclass=\"int-drug\">Levobunolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Levobunolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Levobunolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994924",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994924_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">Noradrenaline/norepinephrine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of elevated blood pressure when given with</ph> <ph otherprops=\"linezolid\" outputclass=\"int-drug\">linezolid</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Noradrenaline/norepinephrine   is predicted to   increase   the risk of elevated blood pressure when given with   linezolid .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Linezolid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994925",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994925_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"lofepramine\" outputclass=\"int-drug\">Lofepramine</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Lofepramine   increases   the effects of   noradrenaline/norepinephrine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lofepramine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994926",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994926_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"metoprolol\" outputclass=\"int-drug\">Metoprolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Metoprolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Metoprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994927",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994927_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"nadolol\" outputclass=\"int-drug\">Nadolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Nadolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nadolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994928",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994928_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"nebivolol\" outputclass=\"int-drug\">Nebivolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Nebivolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nebivolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994929",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994929_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"nortriptyline\" outputclass=\"int-drug\">Nortriptyline</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Nortriptyline   increases   the effects of   noradrenaline/norepinephrine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nortriptyline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994930",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994930_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"opicapone\" outputclass=\"int-drug\">Opicapone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of cardiovascular adverse effects when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Opicapone   is predicted to   increase   the risk of cardiovascular adverse effects when given with   noradrenaline/norepinephrine .  Manufacturer advises monitor .    \n\n"
						}
					],
					"hasOrder": "25",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Opicapone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994931",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994931_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">Noradrenaline/norepinephrine</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"ozanimod\" outputclass=\"int-drug\">ozanimod</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Noradrenaline/norepinephrine   might   increase   the risk of a hypertensive crisis when given with   ozanimod .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "26",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ozanimod</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994932",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994932_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">Noradrenaline/norepinephrine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"phenelzine\" outputclass=\"int-drug\">phenelzine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for 14 days after stopping the MAOI</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Noradrenaline/norepinephrine   is predicted to   increase   the risk of a hypertensive crisis when given with   phenelzine .  Manufacturer advises avoid and for 14 days after stopping the MAOI .    \n\n"
						}
					],
					"hasOrder": "27",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Phenelzine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994933",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994933_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"pindolol\" outputclass=\"int-drug\">Pindolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Pindolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "28",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pindolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994934",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994934_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"propranolol\" outputclass=\"int-drug\">Propranolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Propranolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "29",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Propranolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994935",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994935_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">Noradrenaline/norepinephrine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"rasagiline\" outputclass=\"int-drug\">rasagiline</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Noradrenaline/norepinephrine   is predicted to   increase   the risk of a hypertensive crisis when given with   rasagiline .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "30",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rasagiline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994936",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994936_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">Noradrenaline/norepinephrine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"safinamide\" outputclass=\"int-drug\">safinamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Noradrenaline/norepinephrine   is predicted to   increase   the risk of a hypertensive crisis when given with   safinamide .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "31",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Safinamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994937",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994937_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">Noradrenaline/norepinephrine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"selegiline\" outputclass=\"int-drug\">selegiline</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Noradrenaline/norepinephrine   is predicted to   increase   the risk of a hypertensive crisis when given with   selegiline .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "32",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Selegiline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994938",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994938_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"sotalol\" outputclass=\"int-drug\">Sotalol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Sotalol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "33",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sotalol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994939",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994939_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"timolol\" outputclass=\"int-drug\">Timolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypertension and bradycardia when given with</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Timolol   is predicted to   increase   the risk of hypertension and bradycardia when given with   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "34",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Timolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994940",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994940_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tolcapone\" outputclass=\"int-drug\">Tolcapone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tolcapone   is predicted to   increase   the effects of   noradrenaline/norepinephrine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "35",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tolcapone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994941",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994941_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">Noradrenaline/norepinephrine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of a hypertensive crisis when given with</ph> <ph otherprops=\"tranylcypromine\" outputclass=\"int-drug\">tranylcypromine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid and for 14 days after stopping the MAOI</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Noradrenaline/norepinephrine   is predicted to   increase   the risk of a hypertensive crisis when given with   tranylcypromine .  Manufacturer advises avoid and for 14 days after stopping the MAOI .    \n\n"
						}
					],
					"hasOrder": "36",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tranylcypromine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994942",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2#bnf_i1643857994942_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"trimipramine\" outputclass=\"int-drug\">Trimipramine</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"noradrenaline/norepinephrine\" outputclass=\"int-heading-drug\">noradrenaline/norepinephrine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Trimipramine   increases   the effects of   noradrenaline/norepinephrine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "37",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trimipramine</title>"
					}
				}
			],
			"hasSearchLabel": " Noradrenaline/norepinephrine  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/noradrenalinenorepinephrine-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Noradrenaline/norepinephrine </title>"
			},
			"rdfs:label": "noradrenaline/norepinephrine"
		}
	]
}